SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Jul-24 5:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Option Exercise | 26,073 | $22.59 | $589,116.00 | 50% 52.58K to 78.65K | |
17-Jul-24 5:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Planned Option Sale | 26,073 | $55.00 | $1,434,020.00 | (33%) 78.65K to 52.58K | |
17-Jul-24 5:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Sale (Planned) | 927 | $55.00 | $50,985.00 | (2%) 52.58K to 51.65K | |
28-Jun-24 5:31 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 26-Jun-24 | Private Sale (Planned) | 956 | $44.38 | $42,427.30 | (2%) 53.54K to 52.58K | |
26-Mar-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Option Exercise | 30,000 | $23.98 | $719,400.00 | 55% 54.94K to 84.94K | 4% |
26-Mar-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Private Option Sale | 30,000 | $44.31 | $1,329,160.00 | (35%) 84.94K to 54.94K | |
26-Mar-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Sale | 2,359 | $44.31 | $104,516.00 | (4%) 54.94K to 52.58K | |
20-Mar-24 6:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 4,283 | $38.14 | $163,354.00 | (7%) 59.22K to 54.94K | |
06-Mar-24 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 23,000 | -- | -- | 63% 36.22K to 59.22K | |
12-Feb-24 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-23 | Acquisition (other) | 931 | $14.98 | $13,946.40 | 3% 35.29K to 36.22K | |
12-Feb-24 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 22-May-23 | Acquisition (other) | 891 | $14.98 | $13,347.20 | 3% 34.4K to 35.29K | |
17-Mar-23 5:08 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Mar-23 | Payment of Exercise | 587 | $17.12 | $10,049.40 | (2%) 34.99K to 34.4K | |
03-Mar-23 4:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-23 | Grant | 29,500 | -- | -- | 538% 5.49K to 34.99K | |
27-Jan-23 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-22 | Acquisition (other) | 537 | $15.16 | $8,140.92 | 11% 4.95K to 5.49K | |
29-Jul-22 4:26 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 26-Jul-22 | Sale | 1,152 | $20.70 | $23,846.90 | (19%) 6.1K to 4.95K | |
29-Jul-22 4:26 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-22 | Acquisition (other) | 1,152 | $17.44 | $20,090.90 | 23% 4.95K to 6.1K | |
02-Mar-22 9:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 28-Feb-22 | Grant | 4,950 | -- | -- | 100% 0 to 4.95K |